Decheng Capital’s CG Oncology CGON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $166M | Hold |
6,371,669
| – | – | 41.84% | 1 |
|
|
2025
Q1 | $156M | Hold |
6,371,669
| – | – | 43.77% | 1 |
|
|
2024
Q4 | $183M | Buy |
6,371,669
+892,859
| +16% | +$25.6M | 39.2% | 1 |
|
|
2024
Q3 | $207M | Buy |
5,478,810
+20,000
| +0.4% | +$755K | 48.96% | 1 |
|
|
2024
Q2 | $172M | Hold |
5,458,810
| – | – | 52.81% | 1 |
|
|
2024
Q1 | $240M | Buy |
+5,458,810
| New | +$240M | 32.14% | 2 |
|